Literature DB >> 24046295

Screening with serum galactomannan might be associated with better outcome than symptom-triggered galactomannan testing in allogeneic HSCT recipients with invasive aspergillosis.

Malgorzata Mikulska1, Anna Maria Raiola, Alessio Signori, Elisa Furfaro, Valerio Del Bono, Andrea Bacigalupo, Claudio Viscoli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24046295     DOI： 10.1093/cid/cit565

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  8 in total

1.  Reply to Mikulska et al.

Authors:  Cynthia E Fisher; Wendy Leisenring; Michael Boeckh; Tobias M Hohl
Journal:  Clin Infect Dis       Date:  2013-09-17       Impact factor: 9.079

Review 2.  Molecular and nonmolecular diagnostic methods for invasive fungal infections.

Authors:  Marios Arvanitis; Theodora Anagnostou; Beth Burgwyn Fuchs; Angela M Caliendo; Eleftherios Mylonakis
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

Review 3.  Recent developments in the management of invasive fungal infections in patients with oncohematological diseases.

Authors:  Markus Ruhnke; Stefan Schwartz
Journal:  Ther Adv Hematol       Date:  2016-07-01

4.  Earlier diagnosis of invasive fusariosis with Aspergillus serum galactomannan testing.

Authors:  Marcio Nucci; Fabianne Carlesse; Paola Cappellano; Andrea G Varon; Adriana Seber; Marcia Garnica; Simone A Nouér; Arnaldo L Colombo
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

5.  Hematopoietic stem cell transplantation-50 years of evolution and future perspectives.

Authors:  Israel Henig; Tsila Zuckerman
Journal:  Rambam Maimonides Med J       Date:  2014-10-29

6.  Fatal Mycotic Aneurysm of the Basilar Artery Caused by Aspergillus fumigatus in a Patient with Pituitary Adenoma and Meningitis.

Authors:  Martin Winterholler; Roland Coras; Walter Geißdörfer; Rudolf Rammensee; Philipp Gölitz; Christian Bogdan; Roland Lang
Journal:  Front Med (Lausanne)       Date:  2017-07-18

Review 7.  Galactomannan, a Surrogate Marker for Outcome in Invasive Aspergillosis: Finally Coming of Age.

Authors:  Toine Mercier; Ellen Guldentops; Katrien Lagrou; Johan Maertens
Journal:  Front Microbiol       Date:  2018-04-04       Impact factor: 5.640

8.  Improving survival of acute-on-chronic liver failure patients complicated with invasive pulmonary aspergillosis.

Authors:  Jie Gao; Qing Zhang; Yuankui Wu; Ying Li; Tingting Qi; Congyan Zhu; Sijia Liu; Ruoxi Yu; Qinjun He; Weiqun Wen; Fuyuan Zhou; Yongpeng Chen; Jinjun Chen; Jinlin Hou
Journal:  Sci Rep       Date:  2018-01-17       Impact factor: 4.379
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.